MOH Stock Recent News
MOH LATEST HEADLINES
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MOH remains well-poised for growth, attributable to improved premium revenues, buyouts and an aging U.S. population.
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the fourth quarter and year ending December 31, 2024, after the market closes on Wednesday, February 5, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, February 6, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 6464707. A telephonic replay.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MOH secures key contracts in Michigan and Idaho to expand services for dual-eligible populations, driving growth and strengthening its role in integrated care solutions.
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that the Michigan Department of Health and Human Services (MDHHS) has awarded a contract to Molina's health plan subsidiary, Molina Healthcare of Michigan, to provide a Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP). This new award follows the initial notice of intent to award the HIDE SNP contract announced by the MDHHS on October 9, 2024, and subsequently cancell.
Molina (MOH) reported earnings 30 days ago. What's next for the stock?
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the closing of its previously announced offering of $750 million aggregate principal amount of 6.250% senior notes due 2033 (the “Notes”) sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain persons outside the United States in reliance on.
Rising medical costs and poor earnings from peers like Elevance Health and UnitedHealth have spooked investors, impacting Molina's stock. MOH's upcoming Q3 earnings have downside risks if industry trends prove correct. Despite short-term risks, the Company's roll-up strategy of acquiring smaller insurers makes it a compelling GARP opportunity.